PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 29 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Clinical evidence
Willow bark extracts are used for antipyretic and analgesic benefits [PMID:31801290].
Salix fragilis bark polar extracts demonstrated strong free radical scavenging activity and inhibition of Staphylococcus aureus growth in vitro [PMID:31801290].
Pregnancy & lactation
Evidence summary
PubMed sources
- 1.PMID: 30000964 (2006) — New and Interesting Fungi. 3. · Fungal systematics and evolution
- 2.PMID: 37648031 (2023) — Inter- and intraspecific diversity of Salix bark phenolic profiles - A resource for the pharmaceutical industry. · Fitoterapia
- 3.PMID: 34446108 (2021) — Isoprene-degrading bacteria associated with the phyllosphere of Salix fragilis, a high isoprene-emitting willow of the Northern Hemisphere. · Environmental microbiome
- 4.PMID: 31801290 (2019) — The Health-Promoting Potential of Salix spp. Bark Polar Extracts: Key Insights on Phenolic Composition and In Vitro Bioactivity and Biocompatibility. · Antioxidants (Basel, Switzerland)
- 5.PMID: 26696761 (2015)